Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

NDAQ:MNMD - Post Discussion

Mind Medicine (MindMed) Inc > Why so quiet on here
View:
Post by Trebes on Mar 01, 2022 11:56am

Why so quiet on here

no comments for a while what's going on here
Comment by Nicksonsnowboar on Mar 03, 2022 10:26am
These gimmick sector stocks have had their run. Now it's usually 1 step forward two steps back.  For eternity .  If you can catch the technical upside bounce on occasion good luck . Should be back under a $1 again soon. 
Comment by Dantheman24 on Mar 09, 2022 11:54pm
Lol give it rest. This stock will be more then fine 
Comment by Starkicker on May 18, 2022 3:52pm
And under $1 for 30 days likely results in a NASDAQ delisting.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Dealroom for high-potential pre-IPO opportunities